Prostate cancer data update: numbers and sources
 |
| The rise of prostate cancer (Urological) in the UK from April 2020 to October 2024 |
As I have said elsewhere, I am reading and writing a lot about prostate cancer these days, not just because it is something that numerous friends and I are dealing with in our own lives, but also because it is a large, growing, ageing-population-driven cancer burden. In my opinion, not enough people are aware of this, so I want to leverage my own experience to raise awareness. This post focuses on the numbers, the scale. Separate posts will address the scope, what having prostate cancer means to them what has it.
The scale of prostate cancer is now comparable to that of breast cancer as a public health issue, and in some key numerical measures it has overtaken it: UK deaths, recent UK diagnoses, and projected US new cases. I'm not pointing this out to diminish breast cancer, but to show that prostate cancer has become a similarly major national cancer problem and deserves the same seriousness in public awareness, early detection policy, treatment capacity, and survivorship support.
The chart at the top of this post is from the UK publication Urology News. It notes that "prostate cancer was impacted by the pandemic more than any other cancer. Because people were less likely to visit their GP at the height of the pandemic, more than 14,000 men who should have been diagnosed and referred for treatment were missing from the health system."
Prostate Cancer (PCa) in the US
The American Cancer Society projects 333,830 new prostate cancer cases in 2026, making it the single largest named cancer category in its table of estimated new cancers. That is slightly higher than 324,580 breast cancer cases when female and male breast cancer are counted together. (See the extensive list of sources listed at the end of this post if you needed citations.)
It is important to note that in terms of deaths, breast cancer remains higher in the US: 42,670 projected breast cancer deaths versus 36,320 prostate cancer deaths in 2026. An accurate statement of the situation would be: prostate cancer is now numerically bigger in the US than breast cancer in terms of projected new diagnoses, but not deaths.
The scale is reinforced by population rates. The US National Cancer Institute’s SEER data put prostate cancer at 123.2 new cases per 100,000 men per year, with a death rate of 18.9 per 100,000 men, based on recent incidence and mortality periods. Female breast cancer is still slightly higher by sex-specific incidence rate, at 132.5 new cases per 100,000 women, with the same reported death rate of 18.9 per 100,000 women. Interestingly, the data on absolute case numbers, sex-specific rates, and deaths do not all tell the same story.
The UK PCa picture
In the UK, Cancer Research UK’s current consolidated statistics report about 57,900 new prostate cancer cases per year, or roughly 160 diagnoses a day, using 2019 and 2021–2022 data. Prostate cancer accounts for 14% of all new UK cancer cases and is the most common cancer in men, representing 28% of new male cancer cases.
The UK incidence of PCa has risen sharply over the longer term: CRUK reports that incidence rates in males have increased by 54% since the early 1990s, and are projected to rise a further 14% between 2024–2026 and 2038–2040, reaching about 85,100 new cases a year by 2038–2040.
The UK breast cancer comparison is striking but slightly time-sensitive. CRUK’s consolidated figures still list breast cancer at about 59,400 new cases per year, just above the prostate figure in that dataset. But Prostate Cancer UK, citing the latest NHS figures, reported in January 2026 that UK prostate cancer diagnoses rose from just under 52,000 in 2021 to more than 64,000 in 2022, a 24% increase, making prostate cancer more commonly diagnosed than breast cancer.
On mortality, the UK comparison is already clearer. CRUK reports around 12,300 prostate cancer deaths per year, compared with around 11,200 breast cancer deaths. Prostate cancer is the third most common cause of cancer death in the UK overall and the second most common cause of cancer death in men. Breast cancer remains the second most common cause of cancer death in women, but numerically, prostate cancer now causes slightly more UK deaths each year.
PCa Data Sources
The numbers cited above come from the general and specific sources listed and linked below. These were found using a chatbot (GPT-5.5 Thinking). I have not checked all of them yet — did I mention that I'm undergoing cancer treatment that makes me tired? I suggest care and caution if using these references in your own work or sharing them with others who might not include similar disclaimers.
0 Comments:
Post a Comment